| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Supply CAS 22503-72-6 Idra-21 Powder 99% Idra-21
Introduction
| Product Name | IDRA-21 | Appearance | White powder |
| Molecular Formula | C8H9ClN2O2S | Molecular Weight | 232.687 |
| Cas No. | 22503-72-6 | Boling Point | 405.1±55.0 °C at 760 mmHg |
| Flashing Point | 198.8±31.5 °C | Density | 1.4±0.1 g/cm3 |
IDRA-21 is a relatively new nootropic compound. It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits. It's likely it was developed in 1994 or 1995 as the first clinical trials and peer-reviewed research articles appear in the literature in 1995.
Function
1. Increases in cognition
2. Increased task accuracy
3. Increases in short term memory
4. Potential therapeutic effects on schizophrenia
5. Potential therapeutic effects on depressio
Application
- Idra-21 can increases in cognition
- Idra-21 can increased task accuracy
- Idra-21 can increases in short term memory
- Idra-21 can potential therapeutic effects on schizophrenia
- Idra-21 can potential therapeutic effects on depression
- Idra-21 can neuroprotection
){kind=link}